Related Experiment Videos
Diminished decondensation and DNA synthesis in activated sperm from rats treated with cyclophosphamide
1Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-0645, USA.
Abstract:
Standard andrology tests do not predict fertility or assess the genetic quality of spermatozoa. To address these problems, we have analyzed sperm nuclear activation in vitro using cytoplasmic extracts of Xenopus laevis frog eggs. The objective of this study was to determine if rat sperm chemically damaged in vivo by cyclophosphamide treatment would respond abnormally in an in vitro rat sperm activation assay (RSAA). Male Sprague-Dawley rats were treated for 6 weeks with cyclophosphamide (CP) to induce DNA damage in post-meiotic germ cells. After the treatment period, cauda epididymal sperm were isolated, and incubated in cytoplasmic extracts of X. laevis frog eggs to induce chromatin decondensation and DNA synthesis in vitro. Sperm from treated rats displayed significant decreases in both decondensation and DNA synthesis when compared to sperm from control rats, consistent with the presence of CP-induced DNA crosslinks. No differences in body, testes, or epididymal weights were observed between control and treated rats, nor was sperm count diminished in the treatment group. These results demonstrate that the RSAA can be used to detect damaged sperm chromatin in the absence of detrimental effects on sperm count, and testis and epididymal weights.
Insights
Standard fertility tests are insufficient. This study shows an in vitro rat sperm activation assay (RSAA) can detect chemically damaged sperm DNA, even when sperm count remains normal.
Area of Science:
- Reproductive Biology
- Toxicology
- Biochemistry
Background:
- Standard andrology tests lack predictive power for fertility and assessment of sperm genetic quality.
- Cyclophosphamide (CP) is a chemotherapeutic agent known to induce DNA damage in germ cells.
Purpose of the Study:
- To evaluate the utility of an in vitro rat sperm activation assay (RSAA) using Xenopus laevis egg extracts.
- To determine if CP-induced DNA damage in rat sperm affects their response in the RSAA.
Main Methods:
- Male Sprague-Dawley rats were treated with cyclophosphamide (CP) for 6 weeks.
- Cauda epididymal sperm were isolated and incubated in Xenopus laevis egg cytoplasmic extracts.
- Sperm chromatin decondensation and DNA synthesis were measured in vitro.
Main Results:
- Sperm from CP-treated rats showed significantly reduced chromatin decondensation and DNA synthesis compared to controls.
- These functional deficits in sperm are consistent with CP-induced DNA crosslinks.
- No significant differences were observed in body weight, testes weight, epididymal weight, or sperm count between groups.
Conclusions:
- The rat sperm activation assay (RSAA) effectively detects damaged sperm chromatin.
- RSAA is a sensitive method for identifying sperm DNA damage, independent of effects on sperm count or organ weights.